Orrick has advised San Francisco-based synthetic biology company Twist Bioscience (NASDAQ: TWST) on its $107.4 million follow-on offering.
by Richard Smith | July.06.2020
by Betsy (Colleen) Popken | May.15.2020
The latest trade secret news and analysis from the U.S. and across the globe.
Trends in cybersecurity, data privacy and compliance
The Recorder, 2016
Investor AllStars, 2017
Law360, 4 times
The American Lawyer, 2016
Law360, 2018 and 3 times